MINI FUTURE OPTIONSSCHEIN PUT - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 01:04:51 01/06/2024 am IST | ||
| 11.26 EUR | -3.92% |
|
| Current month | -8.38% | ||
| 1 month | -8.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 11.26 | -3.92% |
| 30/24/30 | 11.72 | -3.54% |
| 29/24/29 | 12.15 | +2.62% |
| 28/24/28 | 11.84 | +0.42% |
| 27/24/27 | 11.79 | -0.34% |
Delayed Quote Deutsche Boerse AG
Last update May 01, 2024 at 01:04 am IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ5S1H |
| ISIN | DE000DJ5S1H7 |
| Date issued | 26/10/2023 |
| Strike | 344.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 8.62 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.64 € |
|---|---|
| Lowest since issue | 7.02 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
224.9
USD
Average target price
284.8
USD
Spread / Average Target
+26.60%
- Stock Market
- Certificates
- Certificat
